BBIO vs. ROIV
Compare and contrast key facts about BridgeBio Pharma, Inc. (BBIO) and Roivant Sciences Ltd. (ROIV).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: BBIO or ROIV.
Key characteristics
| BBIO | ROIV | |
|---|---|---|
| YTD Return | -32.90% | 5.70% |
| 1Y Return | 0.07% | 38.83% |
| 3Y Return (Ann) | -19.06% | 11.85% |
| Sharpe Ratio | -0.14 | 0.99 |
| Sortino Ratio | 0.18 | 1.61 |
| Omega Ratio | 1.02 | 1.18 |
| Calmar Ratio | -0.11 | 0.88 |
| Martin Ratio | -0.23 | 4.45 |
| Ulcer Index | 33.55% | 7.24% |
| Daily Std Dev | 54.89% | 32.61% |
| Max Drawdown | -92.80% | -79.22% |
| Current Drawdown | -62.56% | -12.20% |
Fundamentals
| BBIO | ROIV | |
|---|---|---|
| Market Cap | $5.09B | $8.78B |
| EPS | -$2.64 | $5.73 |
| Total Revenue (TTM) | $215.03M | $121.20M |
| Gross Profit (TTM) | $210.67M | $106.61M |
| EBITDA (TTM) | -$334.96M | -$660.85M |
Correlation
The correlation between BBIO and ROIV is 0.34, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Performance
BBIO vs. ROIV - Performance Comparison
In the year-to-date period, BBIO achieves a -32.90% return, which is significantly lower than ROIV's 5.70% return. The chart below displays the growth of a $10,000 investment in both assets, with all prices adjusted for splits and dividends.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
BBIO vs. ROIV - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for BridgeBio Pharma, Inc. (BBIO) and Roivant Sciences Ltd. (ROIV). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
BBIO vs. ROIV - Dividend Comparison
Neither BBIO nor ROIV has paid dividends to shareholders.
Drawdowns
BBIO vs. ROIV - Drawdown Comparison
The maximum BBIO drawdown since its inception was -92.80%, which is greater than ROIV's maximum drawdown of -79.22%. Use the drawdown chart below to compare losses from any high point for BBIO and ROIV. For additional features, visit the drawdowns tool.
Volatility
BBIO vs. ROIV - Volatility Comparison
BridgeBio Pharma, Inc. (BBIO) has a higher volatility of 13.01% compared to Roivant Sciences Ltd. (ROIV) at 5.68%. This indicates that BBIO's price experiences larger fluctuations and is considered to be riskier than ROIV based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Financials
BBIO vs. ROIV - Financials Comparison
This section allows you to compare key financial metrics between BridgeBio Pharma, Inc. and Roivant Sciences Ltd.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities